You may be eligible for this study if you: Have been diagnosed with type 2 diabetes Have confirmed atherosclerotic cardiovascular disease (a buildup of plaque from atherosclerosis in your blood vessels that can damage your heart and other organs) Have an A1C between 7% and 10.5% Have a BMI greater or equal to 25 kg/m2 Are at least 40 years old Have not had a major cardiovascular event in the last 60 days Do not have a history of severe hypoglycemia and/or hypoglycemia unawareness within the last 6 months If you have had a prior health event such as heart attack, stroke, or angina, or confirmed evidence of damage to the arteries from fatty plaques, contact the number below to find out if you are eligible You can see a full list of eligibility and exclusion criteria here
In both preclinical and early human studies, NMN supplementation has been linked to improved physical performance, better sleep quality, and enhanced exercise capacity
Understanding Semaglutide: A Modern Approach to Weight Management Semaglutide has emerged as a significant advancement in the field of weight management and metabolic health
pseudomembranous candidosis, ATCC
Protecting those cells from environmental stressors is one of the bodys most important jobs
Ipamorelin and Sermorelin are growth hormone-releasing peptides (GHRPs) that work synergistically to naturally stimulate your bodys own production of human growth hormone (HGH)
